![Gordon Naylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gordon Naylor
Amministratore Delegato presso
CSL LIMITED
Patrimonio netto: 3 M $ in data 31/05/2026
Profilo
Gordon Naylor is Chief Executive Officer, MD & Director at CSL Ltd. since 2026.
Mr. Naylor is Independent Non-Executive Director at Orica Ltd. since 2022.
Mr. Naylor is Director at Seqirus Holdings UK Ltd. since 2015.
Mr. Naylor is Senior Vice President & General Manager at CSL Plasma, Inc. Current former roles include Non-Executive Chairman at Medical Developments International Ltd. from 2020 to 2025.
Mr. Naylor was Chief Financial Officer at CSL Ltd. from 2010 to 2016.
Mr. Naylor was EVP-Plasma, Supply Chain & Information Systems at CSL Behring LLC.
Mr. Naylor was President at Seqirus UK Ltd. from 2015 to 2019.
Education includes an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CSL LIMITED 0,01% | 26/05/2026 | 40.819 ( 0,01% ) | 3 M $ | 31/05/2026 |
| 15/08/2025 | 1.045.113 ( 0,93% ) | 289 507 $ | 31/05/2026 | |
| 30/09/2025 | 16.394 ( 0% ) | 269 999 $ | 31/05/2026 |
Posizioni attive di Gordon Naylor
| Società | Posizione | Inizio |
|---|---|---|
| ORICA LIMITED | Direttore/Membro del Consiglio | 01/04/2022 |
| CSL LIMITED | Amministratore Delegato | 11/02/2026 |
CSL Plasma, Inc.
 CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Corporate Officer/Principal | - |
Seqirus Holdings UK Ltd.
 Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | 29/05/2015 |
Precedenti posizioni note di Gordon Naylor
| Società | Posizione | Fine |
|---|---|---|
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Presidente | 01/12/2025 |
Seqirus UK Ltd.
 Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Presidente | 01/06/2019 |
| CSL LIMITED | Direttore Finanziario/CFO | 02/01/2016 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Direttore Finanziario/CFO | - |
Formazione di Gordon Naylor
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
48
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Medical Developments International Ltd.
 Medical Developments International Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical drugs & medical equipment | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orica Ltd.
 Orica Ltd. Industrial SpecialtiesProcess Industries Manufactures and distributes commercial blasting systems & mining and tunneling support systems to the mining and infrastructure markets | Process Industries |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
CSL Plasma, Inc.
CSL Plasma, Inc. Medical/Nursing ServicesHealth Services Collects blood donations | Health Services |
Seqirus UK Ltd.
Seqirus UK Ltd. Pharmaceuticals: MajorHealth Technology Develops and delivers therapies for people living with conditions in the immunology, hematology, cardiovascular, metabolic, respiratory & transplant therapeutic areas | Health Technology |
Seqirus Holdings UK Ltd.
Seqirus Holdings UK Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
